Scandion Oncology logo

Scandion Oncology Investor Relations Material

Scandion Oncology A/S is a clinical-stage biotechnology company, which focuses on developing medicines for the treatment of chemotherapy resistance. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.

Upcoming events for

Q3 20222022-11-16

Latest company events

More about Scandion Oncology

Ticker symbol

SCOL

Country

Sweden

Dig deeper into the Scandion Oncology fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot